<DOC>
	<DOC>NCT00265369</DOC>
	<brief_summary>Primary objective: - To demonstrate the efficacy of a Bacillus clausii probiotic strain compared to placebo in children suffering from acute diarrhoea and treated for 7 days. Secondary objective: - To evaluate the clinical safety of the Bacillus clausii probiotic strain versus placebo.</brief_summary>
	<brief_title>TEDDY: Spores of Bacillus Clausii in Acute Diarrhoea in Children</brief_title>
	<detailed_description />
	<mesh_term>Diarrhea</mesh_term>
	<criteria>Inclusion criteria: Infants or Children Non hospitalized infants or children With acute diarrhea evident for less than 48 hours Having had three or more watery stools during the preceding 24 hours Exclusion criteria: Infants or Children With blood stools Having been treated with antibiotics or probiotics within the two weeks before the enrollment Suffering from dehydration defined by a weight loss of at least 5% or by the presence of a skin fold With an history of seizures With immunosuppressive conditions With a current status requiring an antibiotic treatment Suffering from a chronic disease including chronic diarrhea whatever the origin Having received before inclusion one of the following treatments: Probiotics Prebiotics Drugs with adsorbing properties Drugs that modify intestinal secretion like bismuth subsalicylate, acetorphan Drugs that modify intestinal motility (opiates such as loperamide, atropine and other cholinergic agents). Having participated in another clinical trial in the last 3 months prior to the start of the study</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>36 Months</maximum_age>
	<verification_date>January 2011</verification_date>
</DOC>